MedPath

Antegrade Double-J Stent Placement for the Treatment of Malignant Obstructive Uropathy

Completed
Conditions
Urologic Neoplasms
Interventions
Procedure: Antegrade double-J stent
Registration Number
NCT04649970
Lead Sponsor
Université de Sousse
Brief Summary

Ureteral double- J stent is usually inserted by retrograde approach for the treatment of obstructed upper urinary tract. The antegrade approach, can a suitable alternative in certain situations without the need for general or spinal anesthesia. The present study demonstrates the indications, success rate, and complications of this approach in the treatment of malignant obstructive uropathy.

Detailed Description

Data of consecutive patients in whom antegrade ureteral stent¬ing was performed between January 2013 and February 2020 were retrospectively analysed using patient records and radiology reports. A total of 174 patients (sexe ratio = 0.51, age range 9-91 years; mean age, 54 years) were included in the study.

Ureteral obstruction was caused by bladder cancer (n=92), uterin cancer (n=31), prostate cancer (n=28), colorectal cancer (n= 15) and retroperitoneal tumor (n= 8) (Table 1).

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
174
Inclusion Criteria
  • malignant uropathy obstruction
Exclusion Criteria
  • benign uropathy obstruction

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
malignant uropathyAntegrade double-J stentAntegrade double-J stent
Primary Outcome Measures
NameTimeMethod
number of patient having Antegrade double-J stent placement for the treatment of malignant obstructive uropathy7 years

double j stent placement succeed or failed

Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath